Union Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Union Savings Bank's BMY Position: Q2 2026 in Review
Union Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $9.24K and leaving 9,389 shares worth $541K. The position accounts for 0.22% of the portfolio, ranked #76.
Union Savings Bank first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $800K in Q2 2023. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Union Savings Bank held 9,389 shares of Bristol-Myers Squibb worth $541K as of Q2 2026.
- Union Savings Bank sold 161 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.24K.
- Bristol-Myers Squibb made up 0.22% of Union Savings Bank's portfolio in Q2 2026, its #76 holding.
- Union Savings Bank first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
- Union Savings Bank's Bristol-Myers Squibb position peaked at $800K in Q2 2023.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.